We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Celadon Pharmaceuticals Plc | LSE:CEL | London | Ordinary Share | GB00BDQYGP38 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 1.50 | 2.52% | 61.00 | 57.00 | 65.00 | 61.00 | 59.50 | 59.50 | 12,246 | 14:00:11 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Investment Advice | 149k | -7.14M | -0.1082 | -5.64 | 39.26M |
Hot Features
Premium
RNS Number:8058L
Celsis International PLC
6 June 2000
CELSIS INTERNATIONAL PLC ("the Company")
Application has been made to the Financial Services Authority and the London
Stock Exchange for a listing of 129,375 shares of 1p each to be admitted to
the Official List.
These shares, ranking pari passu in all respects with the existing shares in
issue, will be allotted pursuant to clause 1.3(a)(iii) of the Stock Purchase
Agreement dated 30th September 1997 between Celsis International plc and Mr R
T Hollis and Mr P J Renaud. The Agreement was in connection with the
acquisition of Scientific Associates Inc. In accordance with clause
1.3(a)(iii) Mr R T Hollis and Mr P J Renaud were entitled to a 2000 Earn Out
Amount equivalent to US$100,000.00. The shares were priced, and converted into
sterling, as at 31st March 2000, equating to 129,375 ordinary shares.
Copies of this announcement may be obtained from the Company's Registered
Office for a period of 14 days.
END
LISUUUMWQUPUGMQ
1 Year Celadon Pharmaceuticals Chart |
1 Month Celadon Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
